| Dedicated MR Imaging vs Surgical Staging of Peritoneal Carcinomatosis in Colorectal Cancer (NCT04231175) | The Netherlands Cancer Institute | 2019-10-28 |
| Neoadjuvant Treatment in Rectal Cancer With Radiotherapy Followed by Atezolizumab and Bevacizumab (TARZAN) (NCT04017455) | The Netherlands Cancer Institute | 2019-10-22 |
| Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO (NCT03815890) | The Netherlands Cancer Institute | 2019-10-04 |
| Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed. (NCT04737382) | The Netherlands Cancer Institute | 2019-08-22 |
| Internet-based WOrk-related Cognitive Rehabilitation for Cancer Survivors: a Randomized Controlled Trial (NCT03900806) | The Netherlands Cancer Institute | 2019-08-03 |
| Lymph Drainage Mapping for Tailoring Elective Nodal Irradiation in Head and Neck Cancer (NCT03968679) | The Netherlands Cancer Institute | 2019-07-22 |
| ctDNA Guided Treatment of Early Resistance to Targeted Treatment (NCT04148066) | The Netherlands Cancer Institute | 2019-07-17 |
| Improve Checkpoint-blockade Response in Advanced Urothelial Cancer (NCT03871036) | The Netherlands Cancer Institute | 2019-05-01 |
| Health-related Quality of Life and Late Effects Among SURVivors of Cancer in Adolescence and Young Adulthood: The SURVAYA Study (NCT05379387) | The Netherlands Cancer Institute | 2019-05-01 |
| Assessing Health-related Quality of Life in Sarcoma Patients (NCT04071704) | The Netherlands Cancer Institute | 2019-05-01 |
| Health After eaRly Menopause Due to Oophorectomy (NCT03835793) | The Netherlands Cancer Institute | 2019-02-11 |
| Blood Sampling of Healthy Volunteers for Immunological Research (NCT03819829) | The Netherlands Cancer Institute | 2019-02-05 |
| The MR-Linac Technical Feasibility Protocol (NCT04351204) | The Netherlands Cancer Institute | 2019-01-22 |
| Assess the Safety of Immunotherapy Induction With Tremelimumab and Durvalumab Prior to Chemoradiotherapy and/or Resection in the Treatment (NCT04287894) | The Netherlands Cancer Institute | 2018-12-28 |
| T-DM1 and Osimertinib Combination Treatment to Target HER2 Bypass Track Resistance in EGFR Mutation Positive NSCLC (NCT03784599) | The Netherlands Cancer Institute | 2018-12-18 |
| Afatinib and Cetuximab in Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Positive Non-small-cell Lung Cancer (NCT03727724) | The Netherlands Cancer Institute | 2018-12-04 |
| Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NCT03852979) | The Netherlands Cancer Institute | 2018-11-01 |
| 18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLC (NCT03564197) | The Netherlands Cancer Institute | 2018-10-25 |
| PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study (NCT03686332) | The Netherlands Cancer Institute | 2018-09-25 |
| Sentinel Lymph Node Procedure in Testicular Germ Cell Tumour (NCT03448822) | The Netherlands Cancer Institute | 2018-09-01 |
| Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (NCT03470350) | The Netherlands Cancer Institute | 2018-08-24 |
| ctDNA as a Biomarker for Treatment Response in HNSCC (NCT03540563) | The Netherlands Cancer Institute | 2018-07-16 |
| A Feasibility Study of Niraparib for Advanced, BRCA1-like, HER2-negative Breast Cancer Patients (NCT02826512) | The Netherlands Cancer Institute | 2018-05-15 |
| Clinical Impact of Dedicated MR Staging of Ovarian Cancer (NCT03399344) | The Netherlands Cancer Institute | 2018-04-13 |
| Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC (NCT03341845) | The Netherlands Cancer Institute | 2018-03-28 |
| Preoperative Breast Irradiation (NCT02941835) | The Netherlands Cancer Institute | 2018-03-12 |
| Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA) (NCT03448835) | The Netherlands Cancer Institute | 2018-03-07 |
| Vinorelbine in Advanced BRAF-like Colon Cancer (NCT03482362) | The Netherlands Cancer Institute | 2018-03-01 |
| Early Response Evaluation in NSCLC Patients Treated With Immunotherapy (NCT04082988) | The Netherlands Cancer Institute | 2018-01-23 |
| Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy (NCT03387761) | The Netherlands Cancer Institute | 2018-01-15 |
| Monitoring MRI Changes Before and During Radiotherapy Treatment of Brain Tumors (NCT03394716) | The Netherlands Cancer Institute | 2018-01-12 |
| Multicentric Randomised Trial for Resectable Gastric Cancer (NCT02931890) | The Netherlands Cancer Institute | 2017-12-21 |
| Adaptive Dose-Escalated Multi-modality Image-guided RadiothErapy (NCT03376386) | The Netherlands Cancer Institute | 2017-12-21 |
| Dose-Effect Relation of Salivary Gland Irradiation (NCT03367780) | The Netherlands Cancer Institute | 2017-11-21 |
| AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer (NCT03147040) | The Netherlands Cancer Institute | 2017-11-02 |
| Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer (NCT03126812) | The Netherlands Cancer Institute | 2017-11-01 |
| Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC (NCT02947113) | The Netherlands Cancer Institute | 2017-11-01 |
| Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination. (NCT03348150) | The Netherlands Cancer Institute | 2017-10-01 |
| To Decrease Fatigue With Light Therapy (NCT03242902) | The Netherlands Cancer Institute | 2017-09-20 |
| A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS) (NCT02910895) | The Netherlands Cancer Institute | 2017-09-09 |
| The Impact of a Web-based Patient Decision Aid for Women Considering Breast Reconstruction (NCT03791138) | The Netherlands Cancer Institute | 2017-08-16 |
| "Wait-and-see" Policy for Complete Responders After Chemoradiotherapy for Rectal Cancer (NCT03426397) | The Netherlands Cancer Institute | 2017-05-10 |
| Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel (NCT03295565) | The Netherlands Cancer Institute | 2017-05-07 |
| Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer (NCT03026140) | The Netherlands Cancer Institute | 2017-03-29 |
| ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck Carcinoma (NCT03003637) | The Netherlands Cancer Institute | 2017-02-28 |
| Management of Low-risk (Grade I and II) DCIS (NCT02492607) | The Netherlands Cancer Institute | 2017-02-13 |
| Bioimmunoradiotherapy (Cetuximab/RT/Avelumab) (NCT02938273) | The Netherlands Cancer Institute | 2017-02-01 |
| Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer (NCT02810743) | The Netherlands Cancer Institute | 2017-01-25 |
| Navigated Abdominal Lymph Node Dissections (NCT05867095) | The Netherlands Cancer Institute | 2017-01-24 |
| Carboplatin-cyclophosphamide Combined With Atezolizumab (NCT02914470) | The Netherlands Cancer Institute | 2017-01-01 |
| Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Melanoma Patients (NCT02437279) | The Netherlands Cancer Institute | 2016-11-24 |
| Optimal Neo-adjuvant Combination Scheme of Ipilimumab and Nivolumab (NCT02977052) | The Netherlands Cancer Institute | 2016-11-24 |
| Pre- Versus Postoperative Accelerated Partial Breast Irradiation (NCT02913729) | The Netherlands Cancer Institute | 2016-11-10 |
| Dexamphetamine Sustained Release Pharmacokinetics and Clinical Validation of Dried Blood Spots (NCT02768441) | The Netherlands Cancer Institute | 2016-11-01 |
| The Effectiveness of Patient Navigation in Cancer Care (NCT03305965) | The Netherlands Cancer Institute | 2016-10-15 |
| Docetaxel Versus Intercalated Erlotinib-docetaxel in Patients With Relapsed EGFR Wild Type, ALK Negative Non Squamous Cell Carcinoma (NCT02775006) | The Netherlands Cancer Institute | 2016-10-14 |
| Study With Improved Solubility Pazopanib (NCT02810756) | The Netherlands Cancer Institute | 2016-09-15 |
| Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancer (NCT03066154) | The Netherlands Cancer Institute | 2016-09-01 |
| The Development of a Personalized Decision Aid: Perspectives of Patients and Health Care Professionals on Shared Decision Making and Informational Needs on Radiotherapy for Breast Cancer (NCT02934126) | The Netherlands Cancer Institute | 2016-09-01 |
| Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma (NCT03048474) | The Netherlands Cancer Institute | 2016-09-01 |
| The Drug Rediscovery Protocol (DRUP Trial) (NCT02925234) | The Netherlands Cancer Institute | 2016-08-01 |
| HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma (NCT02836548) | The Netherlands Cancer Institute | 2016-06-01 |
| Lung Cancer Early Molecular Assessment Trial (NCT02894853) | The Netherlands Cancer Institute | 2016-06-01 |
| Food-effect Study on Uracil and Dihydrouracil Levels as a Diagnostic Marker of Dihydropyrimidine Dehydrogenase Activity (NCT02718664) | The Netherlands Cancer Institute | 2016-04-14 |
| Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer (NCT02743923) | The Netherlands Cancer Institute | 2016-04-01 |
| Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin (NCT02695459) | The Netherlands Cancer Institute | 2016-03-30 |
| Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients (NCT02575066) | The Netherlands Cancer Institute | 2016-03-17 |
| Study Comparing Pembrolizumab With Dual MAPK Pathway Inhibition Plus Pembrolizumab in Melanoma Patients (NCT02625337) | The Netherlands Cancer Institute | 2016-01-01 |
| Comparing Two Palliative Schemes of Radiotherapy for Head and Neck Cancer (NCT02421458) | The Netherlands Cancer Institute | 2015-11-01 |
| Treatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223 (NCT03223727) | The Netherlands Cancer Institute | 2015-10-30 |
| Molecular Stool Testing for Colorectal Cancer Surveillance (NCT02715141) | The Netherlands Cancer Institute | 2015-10-01 |
| Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients (NCT02499367) | The Netherlands Cancer Institute | 2015-08-01 |
| Mapping of Sentinel Lymph Node Drainage Using SPECT (SUSPECT) (SUSPECT) (NCT02572661) | The Netherlands Cancer Institute | 2015-07-23 |
| Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLC (NCT02492568) | The Netherlands Cancer Institute | 2015-07-01 |
| Nivolumab in Patients With Recurrent Malignant Mesothelioma (NCT02497508) | The Netherlands Cancer Institute | 2015-07-01 |
| Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer (NCT02450656) | The Netherlands Cancer Institute | 2015-06-01 |
| Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer (NCT02418624) | The Netherlands Cancer Institute | 2015-05-01 |
| Identifying Subgroups With High Cardiovascular Risk in Breast Cancer Survivors (NCT02485626) | The Netherlands Cancer Institute | 2015-04-01 |
| Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of Fluoropyrimidines (NCT02324452) | The Netherlands Cancer Institute | 2015-03-01 |
| Internet-based Cognitive Behavioral Therapy for Breast Cancer Patients With Climacteric Symptoms (NCT02672189) | The Netherlands Cancer Institute | 2015-02-01 |
| Registry of Treatment Outcomes of Symptomatic Metastasized Castration Resistant Prostate Cancer Treated With Radium-223 (NCT03223597) | The Netherlands Cancer Institute | 2015-01-17 |
| Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen (NCT02285179) | The Netherlands Cancer Institute | 2014-11-01 |
| Lapatinib Plus Trametinib in KRAS Mutant NSCLC (NCT02230553) | The Netherlands Cancer Institute | 2014-10-07 |
| Olaparib and Radiotherapy in Head and Neck Cancer (NCT02229656) | The Netherlands Cancer Institute | 2014-09-24 |
| Study Comparing TIL to Standard Ipilimumab in Patients With Metastatic Melanoma (NCT02278887) | The Netherlands Cancer Institute | 2014-09-23 |
| An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries (NCT02247713) | The Netherlands Cancer Institute | 2014-09-01 |
| High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer (NCT01646034) | The Netherlands Cancer Institute | 2014-09-01 |
| Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen Ablation (NCT03297385) | The Netherlands Cancer Institute | 2014-08-28 |
| 4D FDG PET in Esophageal Cancer (NCT02424864) | The Netherlands Cancer Institute | 2014-08-01 |
| Organ Motion and Early Tumor Response Measurement (NCT02139488) | The Netherlands Cancer Institute | 2014-04-18 |
| Dacomitinib Plus PD-0325901 in Advanced KRAS Mutant NSCLC (NCT02039336) | The Netherlands Cancer Institute | 2014-04-02 |
| Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2 (NCT01996267) | The Netherlands Cancer Institute | 2013-12-01 |
| Olaparib and Radiotherapy in Inoperable Breast Cancer (NCT02227082) | The Netherlands Cancer Institute | 2013-10-21 |
| Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases (NCT01818713) | The Netherlands Cancer Institute | 2013-10-01 |
| Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer (NCT01898117) | The Netherlands Cancer Institute | 2013-07-01 |
| Hippocampus Avoidance PCI vs PCI (NCT01780675) | The Netherlands Cancer Institute | 2013-04-01 |
| PET Response During Chemoradiation of Lung Cancer (NCT02315053) | The Netherlands Cancer Institute | 2013-03-21 |
| Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm. (NCT01933568) | The Netherlands Cancer Institute | 2013-02-28 |
| RCT of an Internet-based CBT Program for Sexuality and Intimacy Problems in Women Treated for Breast Cancer (NCT02091765) | The Netherlands Cancer Institute | 2012-12-01 |
| Adaptive Radiation Treatment for Head and Neck Cancer (NCT01504815) | The Netherlands Cancer Institute | 2012-09-07 |